Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2408-2416

  Vakkala, Merja ^a   Kahlos, Katriina ^a   Lakari, Essi ^a   Pääkkö, Paavo ^a   Kinnula, Vuokko ^a   Soini, Ylermi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ADENOCARCINOMA, MUCINOUS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; DNA; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034083406     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Geller, D. A., and Billiar, T. R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev., 17: 7-23, 1998.
2. Moncada, S., Palmer, R. M. J., and Higgs, E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43: 109-142, 1991.
3. Ambs, S., Hussain, S. P., and Harris, C. C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11: 443-448, 1997.
4. Nathan, C., and Xie, Q. Regulation of biosynthesis of nitric oxide. J. Biol. Chem., 269: 13725-13728, 1994.
5. Lala, P. K., and Orucevic, A. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev., 17: 91-106, 1998.
6. Wink, D. A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M. W., and Mitchell, J. Commentary. The multifaceted roles of nitric oxide in cancer. Carcinogenesis (Lond.), 19: 711-721, 1998.
7. Felley-Bosco, E. Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev., 17: 25-37, 1998.
8. Dimmeler, S., and Zeiher, A. M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide, 1: 275-281, 1997.
9. Brüne, B., von Knethen, A., and Sandau K. B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol., 351: 261-272, 1998.
10. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
11. Dueñas-Gonzales, A., Isales, D. M., Abad-Hernandez, M., Gonzalez-Sarmiento, R., Sangueza, O., and Rodriguez-Commes, J., Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol., 10: 645-649, 1997.
12. Mustonen, M., Raunio, H., Pääkkö, P., and Soini, Y. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology, 31: 347-354, 1997.
13. Soini, Y., Pääkkö, P., and Lehto, V-P. Histopathological evaluation of apoptosis in cancer. Am. J. Pathol., 153: 1041-1053, 1998.
14. Vakkala, M., Lähteenmäki, K., Raunio, H., Pääkkö, P., and Soini, Y. Apoptosis during breast carcinoma progression. Clin. Cancer Res., 5: 319-324, 1999.
15. Tavassoli, F. Pathology of Breast. Norwalk, Connecticut: Appleton & Lange, 1992.
16. Elston, C. W., and Ellis, I. O. Classification of breast tumors. The breast. Syst. Pathol., 13: 239-247, 1998.
17. Holland, R., Hendricks, J. H. C. L., Verbeck, A. L. M., Mravunac, M., and Schuurmans-Stekhoven, J. H. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet, 335: 519-522, 1990.
18. Törmänen, U., Eerola, A-K., Vähäkangas, K., Soini, Y., Sormunen, R., Bloigu, R., Lehto, V-P., and Pääkkö, P. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res., 55: 5595-5602, 1995.
19. Soini, Y., Virkajärvi, N., Lehto, V-P., and Pääkkö, P. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer, 73: 1025-1030, 1996.
20. Laemmli, V. K. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature (Lond.), 227: 680-684, 1970.
21. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
22. Alalami, O., and Martin, J. H. J. ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. Cancer Lett., 123: 99-105, 1998.
23. Klotz, T., Bloch, W., Volberg, C., Engelmann, U., and Addicks, K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer (Phila.), 82: 1897-1903, 1998.
24. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994.
25. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58: 334-341, 1998.
26. Kojima, M., Morisaki, T., Tsukahara, Y., Uchiyama, A., Matsunari, Y., Mibu, R., and Tanaka, M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol., 70: 222-229, 1999.
27. Swana, H. S., Smith, S. D., Perrotta, P. L., Saito, N., Wheeler, M. A., and Weiss, R. M. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J. Urol., 161: 630-634, 1999.
28. Moochala, S., Chhatwal, V. J. S., Chan, S. T. F., Ngoi, S. S., Chia, Y. W., and Rauff, A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis (Lond.), 17: 1171-1174, 1996.
29. Dimmeler, S., Haendeler, J., Nehls, M., and Zeiher, A. M. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J. Exp. Med., 185: 601-608, 1997.
30. Kim, Y. M., de Vera, M. E., Watkins, S. C., and Billiar, T. R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducting heat shock protein 70 expression. J. Biol. Chem., 272: 1402-1411, 1997.
31. Mannick, J. B., Asano, K., Izumi, K., Kieff, E., and Stamler, J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell, 79: 1137-1146, 1994.
32. Mannick, J. B., Miao, X. Q., and Stamler, J. S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem., 272: 24125-24128, 1997.
33. Beavais, F., Michel, L., and Dubertret, L. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprives human eosinophiles. FEES Lett., 361: 229-232, 1995.
34. Sarih, M., Souvannavong, V., and Adam, A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun., 191: 503-508, 1993.
35. Kaneto, H., Fujii, J., Seo, H. G., Suzuki, K., Matsuoka, T., Nakamura, M., Tatsumi, H., Yamasaka, Y., Kamada, T., and Taniguchi, N. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes, 44: 733-738, 1995.
36. Hortelano, S., Dallaporta, B., Zamzami, N., Hirsh, T., Susin, S. A., Marzo, I., Bosca, L., and Kroemer, G. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett., 410: 373-377, 1997.
37. Shen, Y. H., Wang, X. L., and Wilcken, D. E. L. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett., 433: 125-131, 1998.
38. Ziche, M., Morbidelli, E., Masini, E., Amerini, S., Granger, H. J., Maggi, C. A., Geppetti, P., and Ledda, F. Nitric oxide mediates angio-genesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94: 2036-2044, 1994.
39. Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A., and Koch, A. E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA, 91: 4190-4194, 1994.
40. Jenkins, D. C., Charles, I. G., Thomson, L. L., Moss. D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396, 1995.
41. G-Nitro-L-Arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am. J. Pathol., 155: 1381-1390, 1999.
42. Pipili-Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., and Maragoudakis, M. E. Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol., 116: 1829-1834, 1995.
43. Pipili-Synetos, E., Sakkoula, E., and Maragoudakis, M. E. Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol., 108: 855-857, 1993.
44. Pipili-Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., and Maragoudakis, M. E. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol., 111: 894-902, 1994.
45. Thomsen, L. L., and Miles, D. W. Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev., 17: 107-118, 1998.
46. Xie, K., and Fidler, I. J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17: 55-75, 1998.
47. Orucevic, A., Bechberger, J., Green, A. M., Shapiro, R. A., Billiar, T. R., and Lala, P. K. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int. J. Cancer, 81: 889-896, 1999.
48. Zeillinger, R., Tantscher, E., Schneeberger, C., Tschugguel, W., Eder, S., Sliutz, G., and Huber, J. C. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res. Treat., 40: 205-207, 1996.
49. Binko, J., and Majewski, H. 17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. Am. J. Physiol., 274: H853-H859, 1998.
50. Cho, M. M., Ziats, N. P., Pal, D., Utian, W. H., and Gorodeski, G. I. Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. Am. J. Physiol., 276: C337-C349, 1999.
51. Hayashi, T., Yamada, K., Esaki, T., Muto, E., Chaudhuri, G., and Iguchi, A. Physiological concentrations of 17 β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages vie a receptor-mediated system. J. Cardiovasc. Pharmacol., 31: 292-298, 1998.
52. Miller, L., Alley, E. W., Murphy, W. J., Russell, S. W., and Hunt, J. S. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J. Leukoc. Biol., 59: 442-450, 1996.